Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
PQD2 Rational Combination of Standard Agents and Immunotherapy to Treat Myeloma
Chesi, Marta
(PI)
Hematology/Oncology
Project
:
Research project
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Multiple Myeloma
100%
Immunotherapy
75%
Standard of Care
32%
Phase II Clinical Trials
27%
Pharmaceutical Preparations
18%
pomalidomide
18%
Immune System
17%
Lenalidomide
14%
Thalidomide
13%
Bone Neoplasms
13%
Proteasome Inhibitors
13%
Interferon Type I
13%
Alkylating Agents
13%
Immunologic Factors
12%
Plasma Cells
11%
Bone Marrow Cells
10%
Interferons
10%
Glucocorticoids
10%
Dendritic Cells
10%
Monocytes
9%
Cell Death
8%
Bone Marrow
8%
Macrophages
7%
Therapeutics
7%
Clinical Trials
7%
Neoplasms
7%
Transplants
7%
Cytokines
6%
DNA
6%